Tag: Global Kinetics

[Global Kinetics in Yahoo Finance] Global Kinetics Corporation Appoints Matthew Garrett As Independent Director to its Board of Directors

“With his proven commercialization and financial leadership expertise in a broad range of successful medical technology and diagnostic companies, I am confident that he will be an invaluable voice on our Board as we continue to bring solutions to market that improve the lives of patients with Parkinson’s disease.” Read...

Read More

Your body, disrupted

In April, scientists at Tel Aviv University “printed” the world’s first 3D vascularized heart using a patient’s own cells and biological material. This is just the tip of the medical iceberg. We expect healthcare to change in the next decade as disruptive technologies promise to improve patient outcomes, making medicine more personalized, effective, and interconnected. The Path to Personal Care: Genetics How similar do you think you are to a banana? You actually share 60% of your genetic code with this healthy snack. DNA is the core building block of every living thing, and minute changes in genetic codes are responsible for unbelievable differences between us. From 23andMe DNA tests providing personalized reports about your ancestry to Igentify revolutionizing genetic testing and counseling, scientists are harnessing our understanding of genetics to provide real value to society. Medicine still relies heavily on general population statistics. The doctor evaluates your symptoms, considers your age, weight, family health history, and ultimately determines treatment. But far too often we simply do not respond and return to the doctor, having wasted money, effort, and time....

Read More

[Global Kinetics in GlobeNewswire] Data Published in Functional Neurology Demonstrate that Global Kinetics’ Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson’s Disease Patients

Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use of data from its wearable FDA-cleared Personal KinetiGraph® (PKG®) provides an objective and more effective approach to assessing motor fluctuations in Parkinson’s Disease (PD) patients compared with patient-reported motor diaries. Study results were published in Functional Neurology.1 Read more...

Read More

Latest from Twitter